Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04687358 · ClinicalTrials.gov registry record

REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients

A clinical trial of Recurrent Pericarditis, sponsored by Kiniksa Pharmaceuticals International.

Active
Registry status
500
Enrollment target
20
Study locations

NCT04687358 is a study of Recurrent Pericarditis that is active but no longer recruiting, run by Kiniksa Pharmaceuticals International. The registered enrollment target is 500 participants, above the 101-participant average among 4 other Recurrent Pericarditis trials with a reported enrollment target (395% higher). The trial reports 20 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04687358, a study of Recurrent Pericarditis, is active but no longer recruiting, sponsored by Kiniksa Pharmaceuticals International.

ACTIVE NOT RECRUITING
Registry status
500 participants
Enrollment target
20
Study locations

Study Summary

The registry will focus on furthering the understanding of the natural history of recurrent pericarditis (RP), as well as document RP-related clinical, health-related quality of life (HRQoL), and economic burden and will assist the medical community to refine or develop data-driven recommendations for clinical management of RP patients to optimize clinical outcomes. It also aims to generate data in support of the impact of rilonacept on clinical outcomes in a real-world population.

Conditions Studied

Recurrent Pericarditis

Study Locations (20)

California

  • University of California San Diego Medical Center - La Jolla
  • Cedars-Sinai Medical Center - Los Angeles
  • Scripps Health - San Diego

Massachusetts

  • Massachusetts General Hospital - Boston
  • Brigham and Women's Hospital - Boston

Minnesota

  • Minneapolis Heart Institute Foundation - Minneapolis
  • Mayo Clinic - PPDS - Rochester

New York

  • NYU Langone Health - New York
  • Northwell Health - Lenox Hill Hospital - New York

Ohio

  • The Linder Research Center at The Christ Hospital - Cincinnati
  • Cleveland Clinic - Cleveland

Alaska

  • Alaska Heart & Vascular Institute - Anchorage

Arizona

  • Pima Heart and Vascular - Tucson

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2021-03-16
Est. Completion 2029-03

Sponsor

Kiniksa Pharmaceuticals International

5 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04687358

The ClinicalTrials.gov registry entry for NCT04687358 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 101-participant average among 4 other Recurrent Pericarditis trials with a reported enrollment target (395% higher). The listed sponsor is Kiniksa Pharmaceuticals International, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Recurrent Pericarditis appearing as the primary indexed condition, and to 0 interventions.

NCT04687358 reports 20 study locations spanning 14 distinct geographic areas - top geographies include California, Massachusetts, Minnesota.

Frequently Asked Questions

What is clinical trial NCT04687358 about?

NCT04687358 is a clinical study titled "REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients". The registry will focus on furthering the understanding of the natural history of recurrent pericarditis (RP), as well as document RP-related clinical, health-related quality of life (HRQoL), and economic burden and will assist the medical community to refine or develop data-driven recommendations f...

What is the current status of trial NCT04687358?

This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2021-03-16. Estimated completion is 2029-03.

What conditions does trial NCT04687358 study?

This clinical trial studies the following conditions: Recurrent Pericarditis.

Who is sponsoring clinical trial NCT04687358?

This trial is sponsored by Kiniksa Pharmaceuticals International, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04687358 being conducted?

This trial has 20 study locations across Alaska, Arizona, California, Illinois, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Recurrent Pericarditis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Recurrent Pericarditis

All registered trials for this condition

Alaska

All trials with a study site in Alaska

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.